|
Agenda Item |
Subject Matter |
Doc. Reference No.
|
|
|
Opening of the Session |
|
|
1. |
Adoption of the Agenda |
CX/NFSDU 04/1 |
|
2. |
Matters Referred to the Committee by the Codex
Alimentarius Commission and/or Other Codex Committees
|
CX/NFSDU 04/2 |
|
3.
|
Guidelines for the Use of Nutrition Claims: Draft Table of
Conditions for Nutrient Contents (Part B Containing
Provisions on Dietary Fibre at Step 7) |
ALINORM
04/27/26, Appendix II
|
|
- Comments at Step 6 |
CX/NFSDU 04/3 |
|
Proposals for a More Inclusive Definition and Related
Methods |
CX/NFSDU 04/3-Add.1 |
|
4.
|
Draft Guidelines for Vitamin and Mineral Supplements at
Step 7 |
ALINORM
04/27/26,
Appendix IV
|
|
- Comments at Step 6 |
CX/NFSDU 04/4 |
|
Report on the Proposals for Additional or Revised Nutrient
Reference Values for Labelling Purposes |
CL 2004/13-NFSDU;
CX/NFSDU 04/4-Add.1 |
|
5. |
(a) Proposed Draft Revised Standard for Infant
Formula at Step 7 |
ALINORM
04/27/26, Appendix V;
CRD 1
|
|
|
- Comments at Step 6 |
CX/NFSDU 04/5 |
|
|
(b) [Proposed Draft Revised Standard for Infant Formula
[and Formulas for Special Medical Purposes Intended for
Infants] ]
Section b: Formulas for Special Medical Purposes Intended
for Infants at Step 4 |
CL 2004/20-NFSDU
|
|
|
- Comments at Step 3 |
CX/NFSDU 04/6 |
|
6. |
Proposed Draft Revised Standard for Processed Cereal-Based
Foods for Infants and Young Children at Step 7
-
Comments at Step 6
|
ALINORM
04/27/26, Appendix VI
|
|
7.
|
Proposed Draft Revision of the Advisory List(s) of Mineral
Salts and Vitamin Compounds for the Use in Foods for
Infants and Children (CAC/GL 10-1979) at Step 4
|
CL 2004/21-NFSDU |
|
|
-
Comments at Step 3 |
CX/NFSDU
04/8 |
|
8.
|
Proposed Draft Recommendations on the Scientific Basis of
Health Claims at Step 4 |
CX/NFSDU 04/9 |
|
|
-
Comments at Step 3 |
CX/NFSDU
04/9-Add.1 |
|
9.
|
Discussion Paper on the Application of Risk Analysis to
the Work of the CCNFSDU |
CX/NFSDU
04/10 |
|
10.
|
Discussion paper on the Definition of Trans-Fatty Acids
|
CX/NFSDU 04/11 |
|
11.
|
Other
Business and Future Work |
|
|
12.
|
Date
and Place of the Next Session |
|
|
13.
|
Adoption of the Report |
|
